 Mura koze amazina yaanye mitwa mundisha Tomas. Nga bando umunyargwanda. Mubu saansgwenbu mushoferi. Ngore ramunara zurgwanda. Nga zeku jiriti bazo chuburgwai. Jiriti bazo chuburgwai nga jambabara murubabu. Haga shiri jihai nga amezin hatatu. Umunjira humunba ichinuti infashe murubabu. Si ima jibdya aribdya umunjira me na ni misozi umunabai iru emu. Ku ga ga tatu jihai kumwano vananoni ichinuti infashe murubabu. Nibu wanai senja muritaro baransu uzum. Bansu uzum yaa mita bahitaba volna umurgwai bazaanga. Ne pati tede badi ekure vananoni bazaanga. Fitemi tibji ima icho tibji ima nacho bazaanga mokansi. Umunjira humunba ichinuti infashe murubabu. Umunjira humunba ichinuti infashe murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Umunjira humunba ichinuti infashe murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibu wanai senja murubabu. Nibunjira humunba ichinuti infashe murubaba. Nibubu wanai senja murubabu. He is clinically much better, his alfafroti protein levels are better and he is subjectively well. We want to watch him how he performs with this kind of a new medication. This is a medicine if it works, can suppress the disease, can increase his lifespan and can give him a good quality of life. So eventually treating him with newer therapies like tear, using oral tablets like matinem and using these new immunotherapies has been very useful in his kind of a cancer. We hope he does well, he responds very well to immunotherapy. We will like to evaluate him with a scan after four doses of immunotherapy with Neuulimal and then we see how he fares to take it to the further text treatment.